Related Experiment Video
Updated: Mar 26, 2026
08:39
Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
Published on: July 4, 2017
9.6K
Curcumin Nanoformulation for Cervical Cancer Treatment
Mohd S Zaman1, Neeraj Chauhan1, Murali M Yallapu1
1Department of Pharmaceutical Sciences and Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, 38163, USA.
Scientific Reports
|February 4, 2016
Summary
This study developed a nanoparticle formulation of curcumin (Nano-CUR) to improve its effectiveness against cervical cancer. Nano-CUR demonstrated significant anti-cancer activity in preclinical models, offering a promising natural treatment option.
Area of Science:
- Oncology
- Nanotechnology
- Natural Products Chemistry
Background:
- Cervical cancer is a leading global cancer in women, with current treatments facing limitations in efficacy and toxicity.
- Conventional chemotherapy often results in poor therapeutic responses and significant systemic side effects.
- Curcumin (CUR), a natural compound, shows anti-cancer potential but suffers from poor bioavailability and rapid degradation, hindering clinical application.
Purpose of the Study:
- To develop a poly(lactic-co-glycolic acid) based nanoparticle formulation of curcumin (Nano-CUR) to enhance its therapeutic efficacy for cervical cancer.
- To evaluate the in vitro and in vivo anti-cancer effects of Nano-CUR compared to free curcumin.
Main Methods:
- Formulation of curcumin nanoparticles using poly(lactic-co-glycolic acid).
- In vitro assessment of Nano-CUR's effects on cervical cancer cell lines, including cell growth inhibition, apoptosis induction, and cell cycle arrest.
- In vivo evaluation in a preclinical orthotopic mouse model of cervical cancer, analyzing tumor burden and molecular markers.
Main Results:
- Nano-CUR significantly inhibited cervical cancer cell growth, induced apoptosis, and arrested the cell cycle more effectively than free CUR.
- Nano-CUR modulated key molecules involved in carcinogenesis, including miRNAs, transcription factors, and proteins.
- In vivo studies showed Nano-CUR reduced tumor burden by downregulating oncogenic miRNA-21, suppressing nuclear β-catenin, and inhibiting HPV oncoproteins (E6/E7) and related inflammatory markers.
Conclusions:
- The poly(lactic-co-glycolic acid) based curcumin nanoparticle formulation (Nano-CUR) overcomes the limitations of free curcumin, exhibiting enhanced anti-cancer properties.
- Nano-CUR demonstrates significant potential as a safe and effective therapeutic agent for cervical cancer based on superior preclinical data.
